Belfast Telegraph

Antrim medical manufacturer to invest £8m in headquarters

Cherith Morris and Mervyn Russell from Fortress Diagnostics accepting the SME Healthcare Business of the Year award at the Belfast Telegraph Business Awards
Cherith Morris and Mervyn Russell from Fortress Diagnostics accepting the SME Healthcare Business of the Year award at the Belfast Telegraph Business Awards

By Mark McConville

A Co Antrim manufacturer of medical devices plans to double its workforce to 84 as it invests more than £8m in a new headquarters.

Fortress Diagnostics, a global provider of in vitro diagnostics for testing samples, said the new facility will "enable more patients to receive better healthcare globally".

The 30,000 square-foot facility at Antrim Technology Park will be a centre for manufacturing, as well as research and development.

The company, which was named SME Healthcare Firm of the Year in this year's Belfast Telegraph Business Awards, said the centre will enable it to manufacture more than 1,000 diagnostic testing products for more than 100 international markets.

Due to open in early 2020, the new facility will host "cutting edge" laboratories using the latest technology. The firm said significant investments have been made in freeze drying, specialist manufacturing and automation in order to create new product lines, develop new markets and increase manufacturing efficiency.

The investment will also see the company double its headcount over the next three years, creating new roles across functions including scientific research and development, production and commercial operations.

Morteza Afrasiabi, managing director of Fortress Diagnostics said: "Over the past 19 years, our highly skilled scientific team has focused on researching, developing and manufacturing innovative quality diagnostic kits to enable healthcare practitioners across the globe to accurately diagnose often life-changing conditions.

Sign In

"Due to our continued success we have now outgrown our current facility and this expansion will allow us to increase our manufacturing capacity to meet a significant increase in customer demand.

"The investment in new technologies will also provide our R&D team with the opportunity to place a strong focus on new product development and the optimisation of our existing tests in order to offer the best quality products on the market."

Rosita Zolnourian, operations director of Fortress Diagnostics, added that it was an "exciting time" for the company. "We are looking forward to moving to our new headquarters and expanding our team, which will no doubt contribute to the continuing growth of our company," she said.

Fortress Diagnostics develops, manufactures and supports clinical diagnostic tests for immunology and haematology laboratories in hospitals, medical centres, clinics, blood banks and research institutions.

Belfast Telegraph

Popular